Integrated Downstream Processing

Over the last decades, the pharmaceutical industry has invested a tremendous amount of resources and capital into the development of continuous processes to improve process efficiency and robustness.

Increasing expression levels in modern cell culture and implementing continuous upstream processes has caused the downstream purification to become the 'bottleneck' in the manufacturing of biopharmaceuticals, especially of monoclonal antibodies.

Download to find out more.

More About This Company